Correlation Between Diffusion Pharmaceuticals and Enveric Biosciences
Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diffusion Pharmaceuticals and Enveric Biosciences, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and Enveric Biosciences.
Diversification Opportunities for Diffusion Pharmaceuticals and Enveric Biosciences
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Diffusion and Enveric is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and Enveric Biosciences go up and down completely randomly.
Pair Corralation between Diffusion Pharmaceuticals and Enveric Biosciences
Given the investment horizon of 90 days Diffusion Pharmaceuticals is expected to under-perform the Enveric Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Diffusion Pharmaceuticals is 2.85 times less risky than Enveric Biosciences. The stock trades about -0.11 of its potential returns per unit of risk. The Enveric Biosciences is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 272.00 in Enveric Biosciences on September 3, 2024 and sell it today you would lose (239.00) from holding Enveric Biosciences or give up 87.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 30.91% |
| Values | Daily Returns |
Diffusion Pharmaceuticals vs. Enveric Biosciences
Performance |
| Timeline |
| Diffusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Enveric Biosciences |
Diffusion Pharmaceuticals and Enveric Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diffusion Pharmaceuticals and Enveric Biosciences
The main advantage of trading using opposite Diffusion Pharmaceuticals and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.| Diffusion Pharmaceuticals vs. Bio Path Holdings | Diffusion Pharmaceuticals vs. Capricor Therapeutics | Diffusion Pharmaceuticals vs. NextCure | Diffusion Pharmaceuticals vs. Tonix Pharmaceuticals Holding |
| Enveric Biosciences vs. Ocean Biomedical | Enveric Biosciences vs. Hepion Pharmaceuticals | Enveric Biosciences vs. Elevation Oncology | Enveric Biosciences vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |